Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
基本信息
- 批准号:9439190
- 负责人:
- 金额:$ 753.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmishAmyloid beta-ProteinArchitectureBiologicalBiologyCase-Control StudiesCell physiologyChromosomesCognitiveCollectionCommunitiesConsanguinityCoupledDNADataData LinkagesData SetDementiaDevelopmentDietEducational BackgroundEmotionalEnvironmental Risk FactorEtiologyFamilyFounder GenerationGene ExpressionGeneral PopulationGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic TranscriptionGenetic VariationGenomicsGenotypeGoalsIn VitroInbreedingIndianaIndividualLife StyleMaintenanceMetabolismOhioOnset of illnessParentsPathway interactionsPhasePlayPopulationProcessPropertyQuality ControlResearchResearch DesignRiskRoleSNP genotypingSamplingScreening procedureSeriesSignal TransductionSurvival AnalysisTestingVariantVertebral columnWorkbasecandidate validationcase controlcognitive testingexomeexperimental studyfollow-upgenetic associationgenetic linkage analysisgenetic pedigreegenetic risk factorgenetic variantgenome sequencinggenomic datanoveloffspringoverexpressionphenotypic dataprotein expressionrare variantreference genomerisk variantscreeningsecondary analysissuccesstau Proteinstransmission processwhole genome
项目摘要
ABSTRACT:
Alzheimer disease (AD) is the most common form of dementia in older individuals. Both genetic and
environmental factors contribute to AD risk, yet despite huge research efforts, a significant portion of the genetic
etiology of AD remains unexplained. Population-wide studies of unrelated AD cases and controls have identified
several common genetic risk factors and through the Alzheimer’s Disease Sequencing Project (ADSP) whole
exome (WES) and whole genome sequencing (WGS) data are being analyzed to identify AD risk modulators.
However, the primary focus of almost all of these studies has been on identifying variants that increase risk;
studies designed to identify variants that may protect from AD are few and usually underpowered. Thus,
additional strategies are required to identify functional variants that protect against or delay the
development of AD. The Amish provide a powerful and unique opportunity to identify variants protecting against
AD whilst controlling for some confounding factors such as level of education, lifestyle and diet. In addition, the
large Amish pedigrees offer an enrichment strategy for identifying rare variants since Mendelian transmissions
from parents to offspring, coupled to inbreeding loops, maximize the chance that multiple copies of rare variants
exist. The primary goal of this project is to identify genetic variations offering protection against AD. The project
will achieve this goal by pursuing three specific aims: (1): Generation of a family-based Amish AD Protective
Variant dataset. We will collect DNA and phenotype data from Amish families in Ohio and Indiana by examining
and following 800 known and newly identified cognitively normal individuals age 80+ and their 1st and 2nd degree
relatives. We will perform SNP genotyping on all samples and WGS on a subset of 200 cognitively normal
individuals; (2): Identification of AD protective variants. Sibships with multiple individuals who are age 80+
and cognitively normal will be analyzed for genetic linkage, IBD segment sharing, and association. Single-marker
analyses will be supplemented by gene-wise analysis and pathway (gene set-based) analysis; (3): Perform
functional validation of candidate protective variants. These experiments will include screening for effects
on gene expression, impact on Aβ or tau processing, and effects on cellular function.
抽象的:
阿尔茨海默病(AD)是老年人中最常见的痴呆症。无论是遗传还是
环境因素会导致 AD 风险,尽管进行了大量的研究工作,但很大一部分遗传因素
AD 的病因仍无法解释。对不相关的 AD 病例和对照进行的全人群研究已确定
几个常见的遗传风险因素并通过阿尔茨海默病测序项目 (ADSP) 整体
正在分析外显子组 (WES) 和全基因组测序 (WGS) 数据,以确定 AD 风险调节剂。
然而,几乎所有这些研究的主要焦点都是识别增加风险的变异。
旨在识别可预防 AD 的变异的研究很少,而且通常力度不够。因此,
需要额外的策略来识别功能变体,以防止或延迟
AD的发展。阿米什人提供了一个强大而独特的机会来识别变种,以防止
AD 同时控制一些混杂因素,如教育水平、生活方式和饮食。此外,
庞大的阿米什血统提供了一种丰富策略,用于识别自孟德尔传播以来的罕见变异
从父母到后代,再加上近亲繁殖循环,最大限度地提高了稀有变异的多个拷贝的机会
存在。该项目的主要目标是识别可预防 AD 的遗传变异。项目
将通过追求三个具体目标来实现这一目标:(1):生成以家庭为基础的阿米什 AD 保护者
变体数据集。我们将通过检查从俄亥俄州和印第安纳州的阿米什家庭收集 DNA 和表型数据
并对 800 名已知和新发现的 80 岁以上认知正常且一级和二级认知正常的个体进行了追踪
亲属。我们将对所有样本进行 SNP 基因分型,并对 200 个认知正常的子集进行全基因组测序 (WGS)
个人; (2):AD保护性变体的识别。与多名 80 岁以上人士有同胞关系
将分析认知正常的遗传连锁、IBD 片段共享和关联。单标记
分析将辅以基因分析和途径(基于基因集)分析; (3):执行
候选保护性变体的功能验证。这些实验将包括筛选效果
对基因表达、对 Aβ 或 tau 加工的影响以及对细胞功能的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan L Haines其他文献
Jonathan L Haines的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan L Haines', 18)}}的其他基金
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
- 批准号:
10448612 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
- 批准号:
10689703 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Epidemiology of Biomarkers of AMD Progression
AMD 进展生物标志物的流行病学
- 批准号:
10489288 - 财政年份:2021
- 资助金额:
$ 753.77万 - 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
- 批准号:
9898659 - 财政年份:2017
- 资助金额:
$ 753.77万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8265101 - 财政年份:2012
- 资助金额:
$ 753.77万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8449079 - 财政年份:2012
- 资助金额:
$ 753.77万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8655882 - 财政年份:2012
- 资助金额:
$ 753.77万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 753.77万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:














{{item.name}}会员




